Literature DB >> 4242768

[Serum enzymes for the diagnosis of experimental acute hepatic necrosis].

A Chalifoux, A Lagacé.   

Abstract

The activity of certain serum enzymes ornithine carbamyl transferase (OCT), serum isocitric dehydrogenase (SIC-D), total serum lactic dehydrogenase (LDH) and its isoenzymes (LD(1) and LD(5)) was evaluated as a mean of assessing experimental hepatic necrosis on dogs treated with CCl(4). Measurement of activity levels of these enzymes, seldom carried out in veterinary clinical pathology, was made together with tests commonly used in our laboratories: serum glutamic pyruvic transaminase (SGPT), serum glutamic oxalacetic transaminase (SGOT) and serum alkaline phosphatase (SAP), cholesterol, bilirubin and prothrombin time. Measurement of the level of OCT was useful in the diagnosis of liver necrosis. The SIC-D level was important during the first four days of the experiment, but on subsequent days, the enzymatic activity was practically normal. Because of the wide variations of LDH serum levels in normal animals and since many factors influence its activity, the measurement of this enzyme and its isoenzymes was not a good index in the diagnosis of canine liver necrosis. The evaluation of cholesterol and bilirubin was judged of secondary importance because these metabolites are not specific to hepatic problems.A small battery of tests must be used to establish a precise diagnosis and a clear prognosis. To the routine tests like those for SGOT, SGPT and SAP, should be added the evaluation of OCT and SIC-D.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4242768      PMCID: PMC1319370     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  33 in total

1.  LIVER BIOPSY IN THE DOG.

Authors:  W L CHAPMAN
Journal:  J Am Vet Med Assoc       Date:  1965-01-15       Impact factor: 1.936

2.  Serum lactic dehydrogenase activity in experimental strangulation obstruction.

Authors:  J J BAHUTH; S M MONROE; H LAUFMAN
Journal:  Q Bull Northwest Univ Med Sch       Date:  1962

3.  Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status.

Authors:  A B GUTMAN
Journal:  Am J Med       Date:  1959-12       Impact factor: 4.965

4.  Serum and tissue transaminase activities in domestic animals.

Authors:  C E CORNELIUS; J BISHOP; J SWITZER; E A RHODE
Journal:  Cornell Vet       Date:  1959-01

5.  Isocitric and 6-phosphogluconic dehydrogenases in human blood serum.

Authors:  S K WOLFSON; H G WILLIAMS-ASHMAN
Journal:  Proc Soc Exp Biol Med       Date:  1957-10

6.  The diagnostic, prognostic and epidemiologic significance of serum glutamic oxaloacetic transaminase (SGO-T) alterations in acute hepatitis.

Authors:  G JERVIS; J S LADUE; F WROBLEWSKI
Journal:  Ann Intern Med       Date:  1956-11       Impact factor: 25.391

7.  Elevation of a serum component in neoplastic disease.

Authors:  B R HILL; C LEVI
Journal:  Cancer Res       Date:  1954-08       Impact factor: 12.701

8.  The study of liver function in dogs.

Authors:  A G GORNALL; C J BARDAWILL
Journal:  Can J Med Sci       Date:  1952-06

9.  Intragastric intubation of small animals.

Authors:  S M Teeter; D R Collins
Journal:  Vet Med Small Anim Clin       Date:  1966-11

10.  Changes in the activity of ornithine carbamyl transferase (O.C.T.) in the serum of cattle and sheep with hepatic lesions.

Authors:  E J Ford
Journal:  J Comp Pathol       Date:  1965-07       Impact factor: 1.311

View more
  2 in total

1.  [Serum ornithine transcarbamylase (OCT) activity in experimental liver diseases in the dog].

Authors:  A Chalifoux
Journal:  Can J Comp Med       Date:  1970-10

2.  The influence of female mice age on biodistribution and biocompatibility of citrate-coated magnetic nanoparticles.

Authors:  Willie O Pinheiro; Maria L Fascineli; Gabriel R Farias; Frederico H Horst; Laise Rodrigues de Andrade; Luis Henrique Corrêa; Kelly Grace Magalhães; Marcelo Henrique Sousa; Marcos C de Almeida; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2019-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.